Skip to main content

Table 1 Association between Cystatin SN expression and clinicopathological variables in 209 ESCC patients

From: Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma

Variables

Cases

Cystatin SN expression (%)

  

Low (−to+)

High (++to+++)

P value*

  

Number. (%)

Number. (%)

 

Age (years)

   

0.166

  Median†

57

   

  Range

32-80

   

  ≤ 57

113

83(73.5)

30(26.5)

 

  > 57

96

62(64.6)

24(35.4)

 

Gender

   

0.328

  Male

150

107(71.3)

43(28.7)

 

  Female

59

38(64.4)

21(35.6)

 

Tumor location

   

0.699

  Upper

15

9(60.0)

6(40.0)

 

  Middle

96

68(70.8)

28(29.2)

 

  Lower

98

68(69.4)

30(30.6)

 

Differentiation

   

0.200

  G1

56

39(69.6)

17(30.4)

 

  G2

105

68(64.8)

37(35.2)

 

  G3

48

38(79.2)

10(20.8)

 

pT status

   

0.133

  pT1

4

1(25.0)

3(75.0)

 

  pT2

62

42(67.7)

20(32.3)

 

  pT3

143

102(71.3)

41(28.7)

 

pN status

   

0.176

  pN0

116

76(65.5)

40(34.5)

 

  pN1-3

93

69(74.2)

24(25.8)

 

pTNM status

   

0.183

  II

133

88(66.2)

45(33.8)

 

  III

76

57(75.0)

19(25.0)

 
  1. *Chi-square test; †median age was 57 years for 209 enrolled ESCC patients.
  2. G grade, pT pathologic tumor, pN pathologic node, pTNM pathologic tumor-node-metastasis.